皮纹症可能是血清病样反应的一个未被发现的特征

IF 5.8 2区 医学 Q1 ALLERGY
A. Suara-Istanbouli, E. Fernandez, C. Stone, A. Norton
{"title":"皮纹症可能是血清病样反应的一个未被发现的特征","authors":"A. Suara-Istanbouli,&nbsp;E. Fernandez,&nbsp;C. Stone,&nbsp;A. Norton","doi":"10.1016/j.anai.2024.08.062","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Serum sickness-like reaction (SSLR) is a syndrome characterized by urticarial-like rash with arthralgia/arthritis. Oral drug challenge is recommended in patients with a history of SSLR to antibiotics. Some studies have reported immediate reactions upon challenge. Previous studies stated that the presence of dermatographism excludes the diagnosis of SSLR. Identifying dermatographism in SSLR patients at time of oral challenge is vital to avoid mislabeling dermatographic urticaria as an immediate drug reaction.</div></div><div><h3>Methods</h3><div>We reviewed patients with SSLR history who presented to clinic between February 2022 to January 2024. Data collected included age, sex, the antibiotic implicated, and the presence of dermatographism on physical exam.</div></div><div><h3>Results</h3><div>Of the 24 patients identified with a history of SSLR, 71% were male, with a median age of 2. The implicated antibiotics included amoxicillin (54%), amoxicillin-clavulanic acid (8%), and cefdinir (38%). 100% of patients tolerated graded oral challenge. On physical exam, 17 of the 24 patients with SSLR had dermatographism, accounting for 71% of the cases. The previously published rate of dermatographism in the general-pediatric population is reported to be 24%. Using a two-sided test of proportion, we found the rate of dermatographism in our cohort was significantly higher compared to the previously published rate in the general-pediatric population (p&lt;0.001).</div></div><div><h3>Conclusion</h3><div>We identified that dermatographism at time of oral challenge is an exam feature associated with SSLR. If reproduced in future studies, this association may redefine SSLR criteria, suggest underlying pathophysiology, or serve as important information to avoid misclassifying minor cutaneous symptoms as drug allergy after oral challenge.</div></div>","PeriodicalId":50773,"journal":{"name":"Annals of Allergy Asthma & Immunology","volume":"133 6","pages":"Pages S11-S12"},"PeriodicalIF":5.8000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"DERMATOGRAPHISM MAY BE AN UNRECOGNIZED FEATURE OF SERUM SICKNESS-LIKE REACTION\",\"authors\":\"A. Suara-Istanbouli,&nbsp;E. Fernandez,&nbsp;C. Stone,&nbsp;A. Norton\",\"doi\":\"10.1016/j.anai.2024.08.062\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Serum sickness-like reaction (SSLR) is a syndrome characterized by urticarial-like rash with arthralgia/arthritis. Oral drug challenge is recommended in patients with a history of SSLR to antibiotics. Some studies have reported immediate reactions upon challenge. Previous studies stated that the presence of dermatographism excludes the diagnosis of SSLR. Identifying dermatographism in SSLR patients at time of oral challenge is vital to avoid mislabeling dermatographic urticaria as an immediate drug reaction.</div></div><div><h3>Methods</h3><div>We reviewed patients with SSLR history who presented to clinic between February 2022 to January 2024. Data collected included age, sex, the antibiotic implicated, and the presence of dermatographism on physical exam.</div></div><div><h3>Results</h3><div>Of the 24 patients identified with a history of SSLR, 71% were male, with a median age of 2. The implicated antibiotics included amoxicillin (54%), amoxicillin-clavulanic acid (8%), and cefdinir (38%). 100% of patients tolerated graded oral challenge. On physical exam, 17 of the 24 patients with SSLR had dermatographism, accounting for 71% of the cases. The previously published rate of dermatographism in the general-pediatric population is reported to be 24%. Using a two-sided test of proportion, we found the rate of dermatographism in our cohort was significantly higher compared to the previously published rate in the general-pediatric population (p&lt;0.001).</div></div><div><h3>Conclusion</h3><div>We identified that dermatographism at time of oral challenge is an exam feature associated with SSLR. If reproduced in future studies, this association may redefine SSLR criteria, suggest underlying pathophysiology, or serve as important information to avoid misclassifying minor cutaneous symptoms as drug allergy after oral challenge.</div></div>\",\"PeriodicalId\":50773,\"journal\":{\"name\":\"Annals of Allergy Asthma & Immunology\",\"volume\":\"133 6\",\"pages\":\"Pages S11-S12\"},\"PeriodicalIF\":5.8000,\"publicationDate\":\"2024-10-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of Allergy Asthma & Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1081120624006070\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Allergy Asthma & Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1081120624006070","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

摘要

导言皮肤病样反应(SSLR)是一种以荨麻疹样皮疹伴关节痛/关节炎为特征的综合征。建议对有抗生素血清病样反应病史的患者进行口服药物挑战。一些研究报告称,挑战后会立即出现反应。以前的研究指出,出现皮疹可排除 SSLR 的诊断。我们回顾了 2022 年 2 月至 2024 年 1 月期间就诊的有 SSLR 病史的患者。结果在24名有SSLR病史的患者中,71%为男性,中位年龄为2岁,涉及的抗生素包括阿莫西林(54%)、阿莫西林-克拉维酸(8%)和头孢地尼(38%)。100%的患者都能耐受分级口服挑战。体格检查结果显示,24 名 SSLR 患者中有 17 人患有皮炎,占病例总数的 71%。据报道,此前公布的普通儿科人群皮纹增多率为 24%。通过双侧比例检验,我们发现与之前公布的普通儿科人群皮纹增多率相比,我们的队列中皮纹增多率明显更高(p<0.001)。如果这种关联在今后的研究中得以重现,则可能重新定义 SSLR 标准,提示潜在的病理生理学,或作为重要的信息,避免在口服药物后将轻微的皮肤症状误诊为药物过敏。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
DERMATOGRAPHISM MAY BE AN UNRECOGNIZED FEATURE OF SERUM SICKNESS-LIKE REACTION

Introduction

Serum sickness-like reaction (SSLR) is a syndrome characterized by urticarial-like rash with arthralgia/arthritis. Oral drug challenge is recommended in patients with a history of SSLR to antibiotics. Some studies have reported immediate reactions upon challenge. Previous studies stated that the presence of dermatographism excludes the diagnosis of SSLR. Identifying dermatographism in SSLR patients at time of oral challenge is vital to avoid mislabeling dermatographic urticaria as an immediate drug reaction.

Methods

We reviewed patients with SSLR history who presented to clinic between February 2022 to January 2024. Data collected included age, sex, the antibiotic implicated, and the presence of dermatographism on physical exam.

Results

Of the 24 patients identified with a history of SSLR, 71% were male, with a median age of 2. The implicated antibiotics included amoxicillin (54%), amoxicillin-clavulanic acid (8%), and cefdinir (38%). 100% of patients tolerated graded oral challenge. On physical exam, 17 of the 24 patients with SSLR had dermatographism, accounting for 71% of the cases. The previously published rate of dermatographism in the general-pediatric population is reported to be 24%. Using a two-sided test of proportion, we found the rate of dermatographism in our cohort was significantly higher compared to the previously published rate in the general-pediatric population (p<0.001).

Conclusion

We identified that dermatographism at time of oral challenge is an exam feature associated with SSLR. If reproduced in future studies, this association may redefine SSLR criteria, suggest underlying pathophysiology, or serve as important information to avoid misclassifying minor cutaneous symptoms as drug allergy after oral challenge.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.50
自引率
6.80%
发文量
437
审稿时长
33 days
期刊介绍: Annals of Allergy, Asthma & Immunology is a scholarly medical journal published monthly by the American College of Allergy, Asthma & Immunology. The purpose of Annals is to serve as an objective evidence-based forum for the allergy/immunology specialist to keep up to date on current clinical science (both research and practice-based) in the fields of allergy, asthma, and immunology. The emphasis of the journal will be to provide clinical and research information that is readily applicable to both the clinician and the researcher. Each issue of the Annals shall also provide opportunities to participate in accredited continuing medical education activities to enhance overall clinical proficiency.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信